万古霉素预防期间耐万古霉素肠球菌的恢复情况。
Recovery of resistant enterococci during vancomycin prophylaxis.
作者信息
Kaplan A H, Gilligan P H, Facklam R R
机构信息
Department of Pediatrics and Medicine, University of North Carolina School of Medicine, Chapel Hill 27514.
出版信息
J Clin Microbiol. 1988 Jun;26(6):1216-8. doi: 10.1128/jcm.26.6.1216-1218.1988.
Abstract
We report a case of a patient undergoing hemodialysis who developed a wound infection and subsequently bacteremia with a strain of vancomycin-resistant enterococcus identified as Enterococcus gallinarum. He had been receiving vancomycin prophylaxis before developing these infections. Both isolates were susceptible to ampicillin, rifampin, teicoplanin, and daptomycin (LY146032).
摘要
我们报告了一例接受血液透析的患者，该患者发生了伤口感染，随后出现菌血症，分离出一株耐万古霉素肠球菌，鉴定为鹑鸡肠球菌。在发生这些感染之前，他一直在接受万古霉素预防治疗。两种分离株对氨苄西林、利福平、替考拉宁和达托霉素（LY146032）均敏感。
相似文献
1
Recovery of resistant enterococci during vancomycin prophylaxis.万古霉素预防期间耐万古霉素肠球菌的恢复情况。
J Clin Microbiol. 1988 Jun;26(6):1216-8. doi: 10.1128/jcm.26.6.1216-1218.1988.
2
Isolation of vancomycin-resistant enterococci in haematologic patients.血液学患者中耐万古霉素肠球菌的分离
Eur J Clin Microbiol Infect Dis. 1991 Jan;10(1):32-4. doi: 10.1007/BF01967094.
3
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria.LY146032（达托霉素）对特定需氧菌的体外活性。
Eur J Clin Microbiol. 1987 Feb;6(1):91-6. doi: 10.1007/BF02097209.
4
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.LY146032（达托霉素）对革兰氏阳性球菌的体外活性比较
Eur J Clin Microbiol. 1987 Feb;6(1):96-9. doi: 10.1007/BF02097210.
5
Bactericidal activity of vancomycin, daptomycin, ampicillin and aminoglycosides against vancomycin-resistant Enterococcus faecium.万古霉素、达托霉素、氨苄西林和氨基糖苷类药物对耐万古霉素屎肠球菌的杀菌活性。
J Antimicrob Chemother. 1990 Nov;26(5):619-26. doi: 10.1093/jac/26.5.619.
6
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估：哨兵计划报告（2003 - 2004年）
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
7
The bactericidal activity of ampicillin, daptomycin, and vancomycin against ampicillin-resistant Enterococcus faecium.氨苄西林、达托霉素和万古霉素对耐氨苄西林屎肠球菌的杀菌活性。
Diagn Microbiol Infect Dis. 1991 Mar-Apr;14(2):141-5. doi: 10.1016/0732-8893(91)90049-l.
8
Enterococci from blood cultures during 1980-1989: susceptibility to ampicillin, penicillin and vancomycin.1980 - 1989年血培养分离出的肠球菌：对氨苄西林、青霉素和万古霉素的敏感性
J Antimicrob Chemother. 1990 Oct;26(4):602-4. doi: 10.1093/jac/26.4.602.
9
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.新型脂肽类抗菌药物LY146032（达托霉素）的体外活性比较
Eur J Clin Microbiol. 1987 Feb;6(1):100-3. doi: 10.1007/BF02097211.
10
European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.1995年革兰氏阳性菌的欧洲糖肽敏感性调查。欧洲糖肽耐药性调查研究组。
Diagn Microbiol Infect Dis. 1998 Aug;31(4):563-71. doi: 10.1016/s0732-8893(98)00053-4.
引用本文的文献
1
Non- non- enterococci: a review of clinical manifestations, virulence factors, and antimicrobial resistance.非肠球菌：临床特征、毒力因子和抗菌药物耐药性综述。
Clin Microbiol Rev. 2024 Jun 13;37(2):e0012123. doi: 10.1128/cmr.00121-23. Epub 2024 Mar 11.
2
Refractory Peritonitis Related to Peritoneal Dialysis Caused by Enterococcus gallinarum.鸡肠球菌相关性难治性腹膜炎导致的腹膜透析相关性腹膜炎。
Intern Med. 2024 Jul 1;63(13):1907-1912. doi: 10.2169/internalmedicine.2373-23. Epub 2023 Nov 20.
3
Alternatives to Fight Vancomycin-Resistant and .对抗耐万古霉素的替代方法及…… （原文不完整，翻译可能不太准确）
Antibiotics (Basel). 2021 Sep 16;10(9):1116. doi: 10.3390/antibiotics10091116.
4
Antibiotic-Induced Pathobiont Dissemination Accelerates Mortality in Severe Experimental Pancreatitis.抗生素诱导的致病共生菌传播加速重症实验性胰腺炎的死亡率。
Front Immunol. 2017 Dec 22;8:1890. doi: 10.3389/fimmu.2017.01890. eCollection 2017.
5
Regional Intraosseous Administration of Prophylactic Antibiotics is More Effective Than Systemic Administration in a Mouse Model of TKA.在全膝关节置换术小鼠模型中，预防性抗生素的区域骨内给药比全身给药更有效。
Clin Orthop Relat Res. 2015 Nov;473(11):3573-84. doi: 10.1007/s11999-015-4464-x. Epub 2015 Jul 30.
6
Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.对体外抗耐甲氧西林金黄色葡萄球菌的唑烷酮类抗菌药物活性的药代动力学-药效学模型的建立。
Antimicrob Agents Chemother. 2009 Dec;53(12):5039-45. doi: 10.1128/AAC.00633-09. Epub 2009 Sep 28.
7
High level resistance to aminoglycosides in enterococci from Riyadh.利雅得地区肠球菌对氨基糖苷类抗生素的高水平耐药性。
Ann Saudi Med. 1994 Jul;14(4):290-3. doi: 10.5144/0256-4947.1994.290.
8
Enterococcus gallinarum endocarditis occurring on native heart valves.发生于自身心脏瓣膜的鹑鸡肠球菌性心内膜炎。
J Clin Microbiol. 2002 Jun;40(6):2308-10. doi: 10.1128/JCM.40.6.2308-2310.2002.
9
Vancomycin-resistant peritonitis associated with peritoneal dialysis: a cause for concern.与腹膜透析相关的耐万古霉素腹膜炎：一个值得关注的问题。
Ir J Med Sci. 2002 Jan-Mar;171(1):42-3. doi: 10.1007/BF03168942.
10
Prevalence of vancomycin-resistant enterococci in fecal samples from hospitalized patients and nonhospitalized controls in a cattle-rearing area of France.法国一个养牛地区住院患者和非住院对照粪便样本中耐万古霉素肠球菌的患病率。
J Clin Microbiol. 2000 Feb;38(2):620-4. doi: 10.1128/JCM.38.2.620-624.2000.
本文引用的文献
1
Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.肠球菌。生物学和流行病学特征以及体外药敏性。
Arch Intern Med. 1982 Oct 25;142(11):2006-9. doi: 10.1001/archinte.142.11.2006.
2
Drug resistance plasmids in Lactobacillus acidophilus and Lactobacillus reuteri.嗜酸乳杆菌和罗伊氏乳杆菌中的耐药质粒。
Appl Environ Microbiol. 1982 Jan;43(1):50-6. doi: 10.1128/aem.43.1.50-56.1982.
3
Common occurrence of plasmid DNA and vancomycin resistance in Leuconostoc spp.明串珠菌属中质粒DNA与万古霉素耐药性的常见情况
Appl Environ Microbiol. 1984 Dec;48(6):1129-33. doi: 10.1128/aem.48.6.1129-1133.1984.
4
Susceptibilities of enterococci to twelve antibiotics.肠球菌对十二种抗生素的敏感性。
Antimicrob Agents Chemother. 1984 Apr;25(4):532-3. doi: 10.1128/AAC.25.4.532.
5
Clinical and microbiologic aspects of serious infections caused by Staphylococcus epidermidis.表皮葡萄球菌引起的严重感染的临床和微生物学特征
Scand J Infect Dis. 1983;15(4):347-60. doi: 10.3109/inf.1983.15.issue-4.05.
6
Emergence of vancomycin resistance in coagulase-negative staphylococci.凝固酶阴性葡萄球菌中万古霉素耐药性的出现。
N Engl J Med. 1987 Apr 9;316(15):927-31. doi: 10.1056/NEJM198704093161507.
7
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.粪肠球菌和屎肠球菌的鉴定以及新型抗菌剂的药敏研究。
J Clin Microbiol. 1987 May;25(5):787-90. doi: 10.1128/jcm.25.5.787-790.1987.
8
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.新型脂肽类抗菌药物LY146032（达托霉素）的体外活性比较
Eur J Clin Microbiol. 1987 Feb;6(1):100-3. doi: 10.1007/BF02097211.
9
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.新型环脂肽抗生素LY 146032的体外和体内活性
Antimicrob Agents Chemother. 1986 Oct;30(4):532-5. doi: 10.1128/AAC.30.4.532.
10
Evaluation of teicoplanin and vancomycin disk susceptibility tests.替考拉宁和万古霉素纸片药敏试验的评估
J Clin Microbiol. 1986 Jan;23(1):100-3. doi: 10.1128/jcm.23.1.100-103.1986.
Zotero 插件